Role of adipocytokines in predicting the development of diabetes and its late complications

被引:47
作者
Gulcelik, Nese Ersoz [1 ]
Usman, Aydan [1 ]
Gurlek, Alper [1 ]
机构
[1] Hacettepe Univ, Sch Med, Dept Endocrinol & Metab, Ankara, Turkey
关键词
Adipocytokines; Diabetes mellitus; Adiponectin; Leptin; Visfatin; Vaspin; Complications; PLASMA VISFATIN CONCENTRATIONS; MOLECULAR-WEIGHT ADIPONECTIN; SERINE-PROTEASE INHIBITOR; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; SERUM ADIPONECTIN; ADIPOSE-TISSUE; MICROVASCULAR COMPLICATIONS; METABOLIC SYNDROME; ENDOTHELIAL DYSFUNCTION;
D O I
10.1007/s12020-009-9234-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes is an important health problem since the incidence of diabetes is continuously increasing. Early diagnosis is important as type 2 diabetes begins long before we diagnose it, leading to a complicated course of the disease. In order to prevent delay in the diagnosis of type 2 diabetes, novel predictors and pathways for type 2 diabetes are mounting. Diabetic complications are common cause of morbidity and mortality among subjects with diabetes. In the pathogenesis of diabetic complications some factors other than chronic hyperglycemia may be involved. Adipocytokines play important roles in the pathogenesis of diabetes mellitus, insulin resistance, and associated metabolic conditions such as hypertension and dyslipidemia. The investigations on the role of adipocytokines in developing diabetes and its complications have been made. In this review, we discussed the implications of adipocytokines in predicting diabetes and diabetic complications, with particular attention on the roles of adiponectin, leptin, visfatin, and vaspin.
引用
收藏
页码:397 / 403
页数:7
相关论文
共 93 条
[71]   Insulin resistance in diabetic microangiopathies [J].
Suzuki, M ;
Kanazawa, A ;
Shiba, M ;
Kojima, H ;
Harano, Y .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2000, 14 (01) :40-45
[72]   Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance [J].
Tan, Bee K. ;
Heutling, Dennis ;
Chen, Jing ;
Farhatullah, S. ;
Adya, Raghu ;
Keay, Stephen D. ;
Kennedy, C. Richard ;
Lehnert, Hendrik ;
Randeva, Harpal S. .
DIABETES, 2008, 57 (06) :1501-1507
[73]   A burning question - Does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? [J].
Tataranni, PA ;
Ortega, E .
DIABETES, 2005, 54 (04) :917-927
[74]  
Temelkova-Kurktschiev T, 2002, DIABETOLOGIA, V45, P151
[75]   Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism [J].
Tschritter, O ;
Fritsche, A ;
Thamer, C ;
Haap, M ;
Shirkavand, F ;
Rahe, S ;
Staiger, H ;
Maerker, E ;
Häring, H ;
Stumvoll, M .
DIABETES, 2003, 52 (02) :239-243
[76]   Is leptin associated with diabetic retinopathy? [J].
Uckaya, G ;
Ozata, M ;
Bayraktar, Z ;
Erten, V ;
Bingol, N ;
Ozdemir, IC .
DIABETES CARE, 2000, 23 (03) :371-376
[77]   Adiponectin: a link between excess adiposity and associated comorbidities? [J].
Ukkola, O ;
Santaniemi, M .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2002, 80 (11) :696-702
[78]  
Wada J, 2008, EXPERT OPIN INV DRUG, V17, P327, DOI [10.1517/13543784.17.3.327, 10.1517/13543784.17.3.327 ]
[79]   Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease [J].
Wannamethee, S. Goya ;
Tchernova, Julia ;
Whincup, Peter ;
Lowe, Gordon D. O. ;
Kelly, Anne ;
Rumley, Ann ;
Wallace, A. Michael ;
Sattar, Naveed .
ATHEROSCLEROSIS, 2007, 191 (02) :418-426
[80]   Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia [J].
Weyer, C ;
Funahashi, T ;
Tanaka, S ;
Hotta, K ;
Matsuzawa, Y ;
Pratley, RE ;
Tataranni, PA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (05) :1930-1935